Skip to main content

Advertisement

Figure 4 | BMC Medical Research Methodology

Figure 4

From: Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension

Figure 4

Network of evidence for comparison of effectiveness of monotherapies and combination therapies for PAH. E are endothelin receptor antagonists, P5 are phosphodiesterase-5 inhibitors, Pr are prostacyclin analogues. Obs indicates that the study is observational, while all others are RCTs. IPD was only available for the IMPRES trial.

Back to article page